VitaNova Life Sciences VNOV Income Statement (2017-2026)

OTC VNOV
$1.38 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
Income Statement Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Revenue & cost
Revenue (Quarter)
0.04M0.03M0.04M0.01M0.01M0.01M0.00M0.03M0.54M0.11M0.29M0.31M1.95M0.10M0.43M0.71M1.78M
Cost of Revenue (Quarter)
0.19M0.04M0.14M0.12M0.80M0.04M0.17M0.39M1.52M
Gross Profit (Quarter)
0.03M0.35M0.07M0.16M0.19M1.16M0.07M0.26M0.32M0.26M
Operating items
Selling, General & Administrative (Quarter)
0.01M0.03M0.02M0.07M0.01M0.01M0.03M0.01M0.02M0.01M0.02M0.03M0.06M0.04M0.03M0.03M0.07M0.12M0.22M0.33M
Other Operating Expenses (Quarter)
0.09M0.06M0.05M0.05M0.05M0.03M0.04M0.05M0.05M
Operating Expenses (Quarter)
0.01M0.03M0.02M0.07M0.01M0.01M0.03M0.01M0.02M0.01M0.02M0.12M0.12M0.09M0.08M0.08M0.10M0.16M0.27M0.37M
Operating Income (Quarter)
-0.01M-0.03M0.00M-0.02M-0.01M0.01M0.23M-0.05M0.06M0.11M1.08M-0.03M0.10M0.05M-0.11M
EBIT (Quarter)
-0.01M-0.03M0.02M-0.03M0.00M0.00M-0.02M-0.00M-0.02M-0.01M0.01M0.23M-0.05M0.06M0.11M1.08M-0.03M0.10M0.05M-0.11M
Non-operating items
Other Non Operating Income (Quarter)
0.15M105.00300.00196.00120.00-0.00M
Non Operating Income (Quarter)
0.15M105.00-0.00M-617.00-0.00M120.000.00M
Net income details
EBT (Quarter)
0.14M0.02M0.01M-0.03M0.00M0.00M-0.02M-0.00M-0.02M-0.01M0.01M0.23M-0.05M0.06M0.11M1.08M-0.03M0.10M0.05M-0.11M
Tax Provisions (Quarter)
0.06M0.01M0.03M0.04M0.28M0.01M0.06M0.09M-0.12M
Profit After Tax (Quarter)
0.14M0.02M0.01M-0.03M0.00M0.00M-0.02M-0.00M-0.02M-0.01M0.01M0.17M-0.06M0.03M0.07M0.80M-0.05M0.04M-0.04M0.02M
Income from Continuing Operations (Quarter)
0.14M0.02M0.01M-0.03M0.00M0.00M-0.02M-0.00M-0.02M-0.01M0.01M0.17M-0.06M0.03M0.07M0.80M-0.05M0.04M-0.04M0.02M
Consolidated Net Income (Quarter)
0.14M0.02M0.01M-0.03M0.00M0.00M-0.02M-0.00M-0.02M-0.01M0.01M0.17M-0.06M0.03M0.07M0.80M-0.05M0.04M-0.04M0.02M
Income towards Parent Company (Quarter)
0.14M0.02M0.01M-0.03M0.00M0.00M-0.02M-0.00M-0.02M-0.01M0.01M0.17M-0.06M0.03M0.07M0.80M-0.05M0.04M-0.04M0.02M
Net Income towards Common Stockholders (Quarter)
0.14M0.02M0.01M-0.03M0.00M0.00M-0.02M-0.00M-0.02M-0.01M0.01M0.17M-0.06M0.03M0.07M0.80M-0.05M0.04M-0.04M0.02M
Additional items
EPS (Basic) (Quarter)
0.020.000.000.000.000.000.000.000.000.000.000.020.000.000.000.030.000.00-0.010.00
EPS (Diluted) (Quarter)
0.020.000.000.000.000.000.000.000.000.000.000.020.000.000.000.030.000.00-0.010.00
Shares Outstanding (Quarter)
5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M6.08M10.64M25.01M25.01M25.01M25.01M25.01M25.01M8.34M8.34M
Shares Outstanding (Diluted) (Quarter)
5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M6.08M10.64M25.01M25.01M25.01M25.01M25.01M25.01M8.34M8.34M
Shares Outstanding (Entity) (Quarter)
5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M5.87M6.08M10.64M25.01M25.01M25.01M25.01M25.01M25.01M8.34M8.34M
EBITDA (Quarter)
-0.01M-0.03M0.02M-0.03M0.00M0.00M-0.02M-0.00M-0.02M-0.01M0.01M0.23M-0.05M0.06M0.11M1.08M-0.03M0.10M0.05M-0.11M
Interest Expenses (Quarter)
0.02M0.02M0.02M0.00M0.00M0.01M0.03M0.02M0.00M0.04M0.00M0.02M
Tax Rate (Quarter)
27.87%-21.57%46.28%32.59%25.94%-42.73%63.93%194.93%116.40%